Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Self-management strategies amongst Australian women with endometriosis: a national online survey

BMC Complementary and Alternative Medicine volume 19, Article number: 17 (2019) Cite this article

Abstract

Background

Endometriosis has a significant negative impact on the lives of women, and current medical treatments often do not give sufficient pain relief or have intolerable side effects for many women. The majority of women with primary dysmenorrhea use self-management strategies (including self-care techniques or lifestyle choices) to help manage period related symptoms, but little is known about self-management in women with endometriosis. The aim of this survey was to determine the prevalence of use, safety, and self-rated effectiveness of common forms of self-management.

Methods

A cross-sectional online survey was distributed via social media using endometriosis support and advocacy groups in Australia between October and December 2017. Women were eligible to answer the survey if they were 18–45, lived in Australia, and had a confirmed diagnosis of endometriosis. Survey questions covered the types of self-management used, improvements in symptoms or reduction in medication, and safety.

Results

Four hundred and eighty-four valid responses were received. Self-management strategies, consisting of self-care or lifestyle choices, were very common (76%) amongst women with endometriosis. The most common forms used were heat (70%), rest (68%), and meditation or breathing exercises (47%). Cannabis, heat, hemp/CBD oil, and dietary changes were the most highly rated in terms of self-reported effectiveness in pain reduction (with mean effectiveness of 7.6, 6.52, 6.33, and 6.39, respectively, on a 10-point scale). Physical interventions such as yoga/Pilates, stretching, and exercise were rated as being less effective. Adverse events were common, especially with using alcohol (53.8%) and exercise (34.2%).

Conclusions

Self-management was very commonly used by women with endometriosis and form an important part of self-management. Women using cannabis reported the highest self-rated effectiveness. Women with endometriosis have unique needs compared to women with primary dysmenorrhea, and therefore any self-management strategies, especially those that are physical in nature, need to be considered in light of the potential for ‘flare ups’.

Peer Review reports

Background

Chronic pelvic pain is pain in the pelvis of greater than 6 months duration that is severe enough to cause functional disability or require medical intervention [1]. Worldwide prevalence rates range between 5.7 and 26.6% [2]. Endometriosis is the presence of endometrial tissue outside the uterine cavity and is the most common cause of chronic pelvic pain [3] with 24 to 40% of women with chronic pelvic pain diagnosed with endometriosis [4, 5]. A recent cohort study of Australian women aged 34–39 years had a prevalence of confirmed endometriosis of 3.7% [6]. Endometriosis related chronic pelvic pain includes a variety of pain symptoms including dysmenorrhea (period pain), dyspareunia (pain during sexual intercourse), dyschezia (pain on bowel motions), and dysuria (pain on urination). In addition to severe pelvic pain [4], endometriosis reduces quality of life and increases absenteeism at work or school [7]. Endometriosis impacts women’s health and wellbeing, including social activities [7], mental and emotional health [8], work and finances [7], and sexual relationships [9], and has been shown to reduce physical quality of life similar to that of cancer patients [7].

Current non-surgical treatments such as non-steroidal anti-inflammatories, oral contraceptive pills, and hormonal treatments have limited effectiveness [10] and the side effect profile is bothersome, with discontinuation rates of between 25 and 50% [11]. Because of this, it is likely that women will use self-care or lifestyle interventions as part of their self-management strategies, to manage either some of their symptoms and/or some of the side effects from the medications, either over the counter or prescribed, used to manage their endometriosis. Use of self-management strategies are incredibly common in women with dysmenorrhea [12, 13]. Women in Australia with symptoms of endometriosis do use complementary therapies [6], and there is evidence of effectiveness of several of these self-management therapies or lifestyle interventions in managing endometriosis symptoms, including dietary changes [14] and yoga [15]. Evidence from other ongoing participant centric research such as ‘Citizen Endo’ [16] suggests that women are using other methods such as cannabis and alcohol to help manage their pain. There is preliminary evidence that the endocannabinoid system can play an important role in managing endometriosis pain [17], and therefore women may be self-medicating with cannabis products to reduce dependence on opioid based pain relief. If women in the community are using self-management and finding it effective this will help direct future research efforts into both studying effectiveness and increasing awareness about effective self-management.

The aim of this survey was to determine the prevalence of use, safety, and self-rated effectiveness of common forms of self-management in women with endometriosis.

Methods

An online questionnaire was developed by the research team in conjunction with 19 women with endometriosis and hosted on the Qualtrics platform (Qualtrics Ltd). Self-management was defined as physical or psychological techniques that women could administer or perform themselves or lifestyle interventions (such as dietary changes, alcohol or cannabis usage) that were undertaken specifically for the management of endometriosis symptoms. An initial list was compiled from endometriosis support online discussions forums and those that had been mentioned as part of the Citizen Endo project [16]. This list was then presented and discussed during two 90-min focus groups that were run in Sydney, Australia in July 2017. Focus groups included 19 women aged 21–45 with Endometriosis. The self-management strategies that women in the focus group had used themselves or that they thought were commonly used in the endometriosis community were included in the questionnaire. Broad categories (e.g. exercise) were adopted in the questionnaire due to the large number of self-management interventions reported by women and to reduce participant burden. All measures were self-reported and required recall over the past 6 months. The questionnaire collected demographics, use of self-management techniques in the previous 6 months, reasons for non-usage of self-management, type and frequency of self-management used, adverse events, self-rated effectiveness and any reduction in endometriosis related medication usage. The Pelvic Pain Impact Questionnaire (PPIQ) was included to assess the severity of pelvic pain in the sample [18]. Five young Australian women (aged 20–27) piloted the survey prior to publication, and minor amendments to wording to improve clarity were made.

The survey took approximately 15–20 min to complete. Features were enabled within Qualtrics that prevented multiple completions from either a single IP address or the same computer. A full copy of the survey can be found in Additional file 1. This article provides an overall summary and comparison of all the surveyed self-management strategies. In depth analysis, including costing, on the highest rated forms of self-management will be published separately.

Women were eligible to participate in the survey if they were aged 18–45, currently living in Australia, and had a diagnosis of endometriosis, confirmed by a laparoscopy within the last 5 years.

Recruitment was conducted via a direct link to the survey and an invitation to participate distributed via the social media platforms (Facebook, Twitter, and Instagram) of Endometriosis Australia and EndoActive, the two Endometriosis advocacy and advice groups in Australia with the most followers on social media. The total combined reach of these patient advocacy organisations on social media is just over 33,000 followers. Each organisation made two social media posts regarding the survey, the first post in October 2017, and the second post 3–5 weeks after the first. The survey link was active from October 2017 to December 2017, for a total of 6 weeks. Data collection was closed once there had been no new responses for 10 days. Data was analysed using SPSS v24 (IBM Corporation). Descriptive statistics were presented as means and standard deviations for continuous data or number and percentages for categorical data. Inferential statistics for between group comparisons were performed using a one-way ANOVA. Statistical significance was set at p < 0.05. Missing data was not replaced. Free text responses on the details of adverse events were imported and then categorized using an Excel spreadsheet (Excel 2016, Microsoft Corporation). Adverse events were broadly categorized based on the free text responses; comments using language such as tired, or exhausted were categorized as fatigue, while sleepiness or hard to stay awake were categorized as drowsiness. Where women used the term ‘flare-up’ it was kept as its own category as this language is often used to describe an increase in not only pain but all endometriosis symptoms. Where ‘flare-up’ was not used, but pain increases were described, responses were categorized based on where the pain was located (if mentioned). Adverse event categories were classed as ‘common’ if more than 25% of women reported them.

This survey was approved by the Western Sydney University Human Research Ethics Committee, approval number H12394, approved 23rd October 2017.

Results

Five hundred and ninety women completed the survey. Ninety-six of the responses were incomplete (less than 25% of the survey complete) and ten responses were excluded as they either did not live in Australia or were outside the age range. A total of 484 responses were suitable for inclusion in the analysis and were used as the denominator for analysis. Table 1 outlines the demographic characteristics of the participants.

Table 1 Characteristics of survey respondents (N = 484)
Full size table

Use of self-management

The most commonly used forms of self-management were heat (70%), rest (68%), and meditation or breathing exercises (47%). For those women who did not use self-management (Table 2) the most common reasons for their non-use was that they did not have enough information to make a decision (36%) and the time commitment (28%) or cost (28%) involved.

Table 2 Reasons for non-use of self-management (N = 109), listed most to least commonly reported
Full size table

Effectiveness of self-management

Women’s self-reported effectiveness (based on a 0–10 score, with 0 being ineffective and 10 being extremely effective) for each self-management intervention (see Table 3) showed that cannabis (7.6 ± 2.0), heat (6.5 ± 1.7), dietary choices (6.4 ± 2.4), hemp/CBD oil (6.3 ± 3.0) and acupressure (6.3 ± 1.6) were the most effective. Physical interventions such as yoga/Pilates (4.5 ± 2.0), stretching (4.6 ± 2.1) and exercise (4.9 ± 2.4) were rated as being less effective. A comparison of the different types of diet (e.g. paleo, vegan, FODMAP) did not show any relationship between a specific diet and self-reported improvement (p = 0.097).

Table 3 Level of self-reported pain relief from self-management modalities, listed from greatest to smallest reported pain reduction
Full size table

When women were asked about the effect self-management had on their need for medications needed to manage their endometriosis symptoms, the most effective was cannabis. Fifty six percent of cannabis users reported being able to reduce their endometriosis related medication by more than 50% and another 27% percent of users reported being able to reduce medication by 25–50%. Other self-management practices were considerably less effective in medication reduction; a third of CBD or hemp oil users reported being able to reduce their endometriosis related medication by 50% or more, while only 18% of those who used a specific diet reported being able to reduce their endometriosis related medication by 50% or more. The full list of each self-management option and its effect on medication is reported in Additional file 2: Table S1.

Adverse events during self-management

Adverse events varied considerably between self-management interventions (Table 4). Alcohol usage showed the greatest number of self-reported adverse events, with just over half (52.8%) of users reporting an adverse reaction. The most common reported events were viesalgia (hangovers) and increases in pain and fatigue after alcohol usage. Exercise also showed a large number of adverse events, with just over one third of women reporting adverse events (34.2%). The most common adverse events were increased pelvic pain (especially cramping pain), increased frequency of ‘flare ups’, and increased fatigue. Heat users reported adverse events (15.9%), most commonly burns. Increased pelvic pain was reported in 15.9% of yoga and Pilates, but these reports were mostly linked to Pilates rather than yoga.

Table 4 Adverse events from self-management modalities, listed from most to least commonly reported
Full size table

Discussion

The use of self-management strategies, especially non-pharmacological practices, in chronic illnesses is common [19]. Women with endometriosis often feel frustrated at the lack of effective medical treatments and therefore turn to self-management [20] as one of the coping strategies to manage their condition [21]. Women with endometriosis often feel disempowered [20], and self-management strategies may help them feel a sense of agency and empowerment [22]. Our survey findings support this: both self-management techniques and lifestyle interventions or modifications are a common and important part of Australian women’s self-management strategy when dealing with the symptoms of endometriosis.

Usage of self-management was high in women with endometriosis, with overall rates of self-management being similar to those observed in women with primary dysmenorrhea [13]. The use of self-management techniques that includes components that may be considered to be ‘complementary’ or ‘alternative’ such as yoga or acupuncture can form an important part of self-management for women, and are often [23], but not always [20], seen as an adjunct rather than a replacement for, mainstream medical care.

The mean age of women in our study (31 years old) is similar to other studies on women with endometriosis in Europe (33 years) [7], South Africa (33 years) [21] and previous research undertaken in Australia (31 years) [24]. The impact of endometriosis on the lives of women in this study is comparable to worldwide impact reports [18]. The greatest impacts were in energy levels, gastrointestinal function, and mood, which may directly relate to the choices of self-management strategies that women make. For example, women with endometriosis may use yoga, cannabis or hemp/CBD oil to improve their mood and make dietary changes to self-manage gastrointestinal problems.

Diet, while not as commonly used as rest and heat, was used by almost half the women in the survey. Diet had high self-reported improvement scores and examination of the types of diets used showed there was significant diversity; with paleo, vegan, gluten free, FODMAP and Mediterranean diets being the most common sub-types of diet. Given the significant proportion of women with endometriosis who also have gastrointestinal [25] and IBS-like symptoms [14], dietary changes, such as a FODMAP diet, may reduce pelvic pain symptoms that could be exacerbated by IBS or gastrointestinal symptoms. This is likely to occur via a reduction in intestinal distention and subsequent reduction in visceral nerve activation [14]. In our survey, there was no specific sub-type of diet reported that was related to a significantly greater self-rated improvement. This appears to be in line with current reviews which find there are no consistent dietary predictors for endometriosis [26].

Heat was the only modality that was both commonly used and rated as effective by women. There are no studies looking specifically at heat for endometriosis related pain but previous research provides evidence that heat reduces primary dysmenorrhea [27]. Heat may work via both increasing blood flow in the abdominal area [28] and by the ‘gate control’ theory of pain inhibition, where topical heat activates thermoreceptors, inhibiting concurrent nociceptive signals reaching the brain [27]. However, despite its effectiveness, a significant number of women reported adverse events with heat, most commonly burns. Therefore, consideration should be given to the use of heat patches that deliver controlled heat at a safe temperature.

The first reported use of cannabis being used as a medicine for female reproductive complaints was in China ca. 2700 BCE. More recently, phytochemical constituents within the plant such as the cannabinoids ∆9-Tetrahydrocannabinol (THC) [29, 30], ∆9-Tetrahydrocannabivarin (THCV) [31] and Cannabidiol (CBD) [32] have demonstrated noted pharmacological activity, specifically analgesic and anti-inflammatory effects. Cannabis, while only used by 13% of women in this survey, had the highest pain relief score and greatest reduction in medication usage of any strategy assessed. This latter finding is mirrored in other international cannabis studies showing a reduction in pharmaceutical medication usage for pain management, with recent evidence demonstrating that cannabis may assist in de-prescribing from pharmaceutical medication, particularly opiates and benzodiazepines, in what is dubbed the substitution effect [33]. Whilst further studies specific to the endometriosis population are required, considering the known abuse, risk of addiction and overdose mortality rates with opiate medications [34], coupled with recent evidence suggesting medicinal cannabis can reduce prescription opiate overdose mortality rates significantly [35], quality assured medicinal cannabis may play a role as both an adjunct analgesic and harm reduction agent. Australia introduced the Narcotic Drugs Regulation in December 2016 to legalise cannabis for medicinal use, with medical practitioners being able to prescribe cannabis products through various avenues including the Special Access Scheme and Authorised Prescriber pathways. Whilst government pathways do not preclude endometriosis or pelvic pain patients from access in Australia, current numbers of approved patients based on clinical indication is suggestive that survey respondents were utilising illicit cannabis.

Both rest and physical activity have been reported as effective self-management practices in women with primary dysmenorrhea [12, 36]; however, the findings in the current survey did not find these methods effective for women with endometriosis, and even found high levels of adverse events due to physical activity. That rest and physical activity are not effective self-management methods in endometriosis is not altogether unsurprising; rest is considered a passive treatment that is ineffective in many chronic pain conditions [37, 38], as it is thought to promote illness behaviour [39] and fear-avoidance behaviour [40]. Similarly, engaging in vigorous physical activity after a period of rest or reduced levels of activity is ineffective in treating chronic pain conditions [41] and can often make pain symptoms worse – inducing a so called ‘flare up’. In women with endometriosis, vigorous exercise may exacerbate pelvic muscle spasms that are commonly seen in these women [42]. While physical activity is essential for chronic pain recovery [43], it needs to be gradual (graded exposure) to avoid flare ups, to improve physical activity tolerance, and to allow individuals to return to their usual level of daily activity [41].

There are clear strengths to this study. First, women must have had endometriosis diagnosed via laparoscopy within the previous 5 years, providing a specific population. Despite laparoscopic investigation being the gold standard in diagnosing endometriosis, some research studies continue to include women with diagnoses of endometriosis based on symptomology reports alone, leading to potential bias from differential or overlapping conditions. Second, the sample size obtained was large in comparison to other survey methodologies with similar populations. Finally, the online survey methodology allowed participants to have anonymity. Greater anonymity improves the willingness of participants to disclose sensitive information [44], such as drug use, which increases the confidence that the present results truly reflect all self-management measures taken by women with endometriosis.

Importantly, the findings from this study should be taken into consideration with the study limitations. Due to the use of social media as a recruitment tool, calculating a response rate is not possible, therefore any generalisability of these findings must be done with caution. Women recruited via support/advocacy groups often have more severe symptoms than those recruited via other methods [45]; however, our sample had very similar PPIQ scores to a large international sample [18]. A small portion of the population came from remote regions of Australia. Arguably, women in remote regions may use different self-management measures due to the decreased availability of medical resources; however, the small sample size obtained did not allow for any analyses that might detect differences. In addition, the questionnaire offered no free response section in which women could nominate other self-management measures not listed. There is the potential that women with endometriosis use additional or alternative self-management measures, but this information was not able to be captured by this questionnaire. Reporting of reduction in endometriosis related medication did not collect data on what class of medication (e.g. analgesics) were being reduced. To reduce survey length, broad categories were used and therefore comparisons between specific sub-types (e.g. walking vs vigorous exercise) was not possible. Combination of yoga and Pilates into one category may obscure the effect of these two practices, as demonstrated by the free text reporting for adverse events with Pilates. Finally, all measures were self-reported, therefore all indications of effectiveness and adverse events are based on women’s own recall, and this may lead to either over or underestimation of benefits and harms.

Conclusions

Given the lack of a ‘cure’ for endometriosis, effective self-management techniques and lifestyle changes may play an important role in ongoing self-management by empowering women to take more control over their own health and providing an effective adjunct to their current treatment regimes. Women with endometriosis have unique needs compared to women with primary dysmenorrhea, and therefore any self-management practices, especially those that are physical in nature, need to be considered in light of the potential for ‘flare ups’. Cannabis users report significant effectiveness for reducing endometriosis related pain and related symptoms, however the number of women using it is small and outcomes all self-reported, therefore future clinical trials in this area are required to determine any possible role in endometriosis management utilising legally obtained and quality assured medicinal cannabis. Medicinal cannabis is becoming available in a growing number of locations but remains illegal for treating pelvic pain in many countries. Therefore, cannabis should only be considered as a possible self-management option by those who can obtain medicinal cannabis through legal means.

Abbreviations

CBD:

Cannabidiol

FODMAP:

Fermentable oligosaccharides, disaccharides, monosaccharides and polyols

PPIQ:

Pelvic pain impact questionnaire

THC:

Tetrahydrocannabinol

References

  1. 1.

    Howard F, Perry P, Carter J, El-Minawi A. Pelvic pain: diagnosis and management. Philadelphia: Lippincott Williams and Wilkins; 2000.

  2. 2.

    Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician. 2014;17(2):E141–7.

  3. 3.

    Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ. 2014;348:g1752.

  4. 4.

    Whitaker LH, Reid J, Choa A, McFee S, Seretny M, Wilson J, Elton RA, Vincent K, Horne AW. An exploratory study into objective and reported characteristics of neuropathic pain in women with chronic pelvic pain. PLoS One. 2016;11(4):e0151950.

  5. 5.

    Mowers EL, Lim CS, Skinner B, Mahnert N, Kamdar N, Morgan DM, As-Sanie S. Prevalence of endometriosis during abdominal or laparoscopic hysterectomy for chronic pelvic pain. Obstet Gynecol. 2016;127(6):1045–53.

  6. 6.

    Fisher C, Adams J, Hickman L, Sibbritt D. The use of complementary and alternative medicine by 7427 Australian women with cyclic perimenstrual pain and discomfort: a cross-sectional study. BMC Complement Altern Med. 2016;16:129.

  7. 7.

    Nnoaham KE, Hummelshoj L, Webster P, d'Hooghe T, de Cicco Nardone F, de Cicco Nardone C, Jenkinson C, Kennedy SH, Zondervan KT, World Endometriosis Research Foundation Global Study Of Women’s Health c: Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 2011, 96(2):366–373 e368.

  8. 8.

    Sepulcri Rde P, do Amaral VF. Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol. 2009;142(1):53–6.

  9. 9.

    Pluchino N, Wenger JM, Petignat P, Tal R, Bolmont M, Taylor HS, Bianchi-Demicheli F. Sexual function in endometriosis patients and their partners: effect of the disease and consequences of treatment. Hum Reprod Update. 2016;22(6):762–74.

  10. 10.

    Brown J, Farquhar C. Endometriosis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2014;3:CD009590.

  11. 11.

    Sinaii N, Cleary SD, Younes N, Ballweg ML, Stratton P. Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience. Fertil Steril. 2007;87(6):1277–86.

  12. 12.

    Banikarim C, Chacko MR, Kelder SH. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med. 2000;154(12):1226–9.

  13. 13.

    Hillen TI, Grbavac SL, Johnston PJ, Straton JA, Keogh JM. Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health. 1999;25(1):40–5.

  14. 14.

    Moore JS, Gibson PR, Perry RE, Burgell RE. Endometriosis in patients with irritable bowel syndrome: specific symptomatic and demographic profile, and response to the low FODMAP diet. Aust N Z J Obstet Gynaecol. 2017;57(2):201–5.

  15. 15.

    Goncalves AV, Barros NF, Bahamondes L. The practice of hatha yoga for the treatment of pain associated with endometriosis. J Altern Complement Med. 2017;23(1):45–52.

  16. 16.

    Challenge #1 Results [https://medium.com/@citizen_endo/challenge-1-results-88b62abd96b]. Accessed 10 Feb 2018.

  17. 17.

    Bouaziz J, Bar On A, Seidman DS, Soriano D. The clinical significance of endocannabinoids in endometriosis pain management. Cannabis Cannabinoid Res. 2017;2(1):72–80.

  18. 18.

    Chalmers KJ, Catley MJ, Evans SF, Moseley GL. Clinical assessment of the impact of pelvic pain on women. Pain. 2017;158(3):498–504.

  19. 19.

    MacKichan F, Paterson C, Henley WE, Britten N. Self-care in people with long term health problems: a community based survey. BMC Fam Pract. 2011;12:53.

  20. 20.

    Culley L, Law C, Hudson N, Denny E, Mitchell H, Baumgarten M, Raine-Fenning N. The social and psychological impact of endometriosis on women's lives: a critical narrative review. Hum Reprod Update. 2013;19(6):625–39.

  21. 21.

    Roomaney R, Kagee A. Coping strategies employed by women with endometriosis in a public health-care setting. J Health Psychol. 2016;21(10):2259–68.

  22. 22.

    Armour M, Dahlen HG, Smith CA. More than needles: the importance of explanations and self-care advice in treating primary dysmenorrhea with acupuncture. Evid Based Complement Alternat Med. 2016;2016:3467067.

  23. 23.

    Thorne S, Paterson B, Russell C, Schultz A. Complementary/alternative medicine in chronic illness as informed self-care decision making. Int J Nurs Stud. 2002;39(7):671–83.

  24. 24.

    Moradi M, Parker M, Sneddon A, Lopez V, Ellwood D. Impact of endometriosis on women’s lives: a qualitative study. BMC Womens Health. 2014;14(1):123.

  25. 25.

    Ek M, Roth B, Ekstrom P, Valentin L, Bengtsson M, Ohlsson B. Gastrointestinal symptoms among endometriosis patients-a case-cohort study. BMC Womens Health. 2015;15:1472–6874 (Electronic).

  26. 26.

    Parazzini F, Vigano P, Candiani M, Fedele L. Diet and endometriosis risk: a literature review. Reprod BioMed Online. 2013;26(4):323–36.

  27. 27.

    Akin M, Price W, Rodriguez G, Erasala G, Hurley G, Smith RP. Continuous, low-level, topical heat wrap therapy as compared to acetaminophen for primary dysmenorrhea. J Reprod Med. 2004;49(9):739–45.

  28. 28.

    Kuntz A. Anatomic and physiologic properties of cutaneous-visceral vasomotor reflex arcs. J Neurophysiol. 1945;8:421–9.

  29. 29.

    Aggarwal SK. Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results. Clin J Pain. 2013;29(2):162–71.

  30. 30.

    Rahn EJ, Hohmann AG. Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. Neurotherapeutics. 2009;6(4):713–37.

  31. 31.

    Bolognini D, Costa B, Maione S, Comelli F, Marini P, Di Marzo V, Parolaro D, Ross RA, Gauson LA, Cascio MG, et al. The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. Br J Pharmacol. 2010;160(3):677–87.

  32. 32.

    Upton R, ElSohly M, Romm A, Russo E, Sexton M, editors. Cannabis inflorescence. Scotts Valley: American Herbal Pharmacopoeia; 2013.

  33. 33.

    Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients. Int J Drug Policy. 2017;42:30–5.

  34. 34.

    Lucas P. Rationale for cannabis-based interventions in the opioid overdose crisis. Harm Reduct J. 2017;14(1):58.

  35. 35.

    Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014;174(10):1668–73.

  36. 36.

    Matthewman G, Lee A, Kaur JG, Daley AJ. Physical activity for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2018;219(3):255.e1–255.e20.

  37. 37.

    Sumpton JE, Moulin DE. Fibromyalgia: presentation and management with a focus on pharmacological treatment. Pain Research and Management. 2008;13(6):477–83.

  38. 38.

    Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, Mannion AF, Reis S, Staal J, Ursin H. Chapter 4 European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006;15:s192–300.

  39. 39.

    Lively MW. Sports medicine approach to low back pain. South Med J. 2002;95(6):642–6.

  40. 40.

    Alappattu MJ, Bishop MD. Psychological factors in chronic pelvic pain in women: relevance and application of the fear-avoidance model of pain. Phys Ther. 2011;91(10):1542–50.

  41. 41.

    Butler DS, Moseley GL. Explain pain 2nd Edn: Noigroup Publications; 2013.

  42. 42.

    Awad E, Ahmed HAH, Yousef A, Abbas R. Efficacy of exercise on pelvic pain and posture associated with endometriosis: within subject design. J Phys Ther Sci. 2017;29(12):2112–5.

  43. 43.

    Geneen LJ, Moore A, Clarke C, Martin D, Colvin LA, Smith BH. Physical activity and exercise for chronic pain in adults: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;4:CD011279.

  44. 44.

    Lessler JT, O’Reilly JM. Mode of interview and reporting of sensitive issues: design and implementation of audio computer-assisted self-interviewing. NIDA Res Monogr. 1997;167(366):382.

  45. 45.

    De Graaff AA, Dirksen CD, Simoens S, De Bie B, Hummelshoj L, D'Hooghe TM, Dunselman GAJ. Quality of life outcomes in women with endometriosis are highly influenced by recruitment strategies. Hum Reprod. 2015;30(6):1331–41.

Download references

Acknowledgements

Thank you to Endometriosis Australia and EndoActive for their support in the promotion of this survey.

Funding

No external funding was provided. Western Sydney University provided funding for all authors as part of their normal academic roles.

Availability of data and materials

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.

Author information

Affiliations

  1. NICM Health Research Institute, Western Sydney University, Building 5, Campbelltown Campus, Locked Bag 1797, Penrith, Sydney, NSW, 2751, Australia
    • Mike Armour
    • , Justin Sinclair
    •  & Caroline A. Smith
  2. School of Science and Health, Western Sydney University, Sydney, Australia
    • K. Jane Chalmers
Authors
  1. Search for Mike Armour in:
  2. Search for Justin Sinclair in:
  3. Search for K. Jane Chalmers in:
  4. Search for Caroline A. Smith in:

Contributions

MA and JS conceptualised the survey, MA, JS, KJC and CS designed the survey questions, MA and JS performed the data analysis, MA drafted the manuscript, JS, KJC and CS provided critical feedback and edits to the draft. All authors approved the final manuscript.

Corresponding author

Correspondence to Mike Armour.

Ethics declarations

Ethics approval and consent to participate

This survey was approved by the Western Sydney University Human Research Ethics Committee, approval number H12394. Participants were advised in the participant information sheet and survey introduction (prior to starting the survey) that consent was implied by completing the survey.

Consent for publication

Not applicable

Competing interests

MA, JS and CS: As a medical research institute, NICM Health Research Institute receives research grants and donations from foundations, universities, government agencies and industry. Sponsors and donors provide untied and tied funding for work to advance the vision and mission of the Institute. This survey was not specifically supported by donor or sponsor funding to NICM.

In addition, JS sits on the Scientific Advisory Board for BioCeuticals. He is also on the Scientific Advisory Board for United in Compassion in a pro bono capacity.

KJC: None known.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional files

Additional file 1:

A Survey tool. Full copy of survey used for data collection. (PDF 284 kb)

Additional file 2:

Table S1. Reduction in medication usage due to the use of self-management. Changes in endometriosis related medication for all self-management modalities. (DOCX 22 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Armour, M., Sinclair, J., Chalmers, K.J. et al. Self-management strategies amongst Australian women with endometriosis: a national online survey. BMC Complement Altern Med 19, 17 (2019). https://doi.org/10.1186/s12906-019-2431-x

Download citation

Keywords

  • Self-management
  • Self-care
  • Endometriosis
  • Exercise
  • Heat
  • Cannabis

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us